Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Post by august202013on Oct 12, 2021 11:49am
202 Views
Post# 33997405

PASS A RESOLUTION AT THE NEXT AGM TO APPIONT AS CEO 23 MTS

PASS A RESOLUTION AT THE NEXT AGM TO APPIONT AS CEO 23 MTSVOTE ME AS A FOR A TEMPORARILY CEO FOR 23 MONTHS AND I WILL DELIVER SALES FOR MIR COVID19 TEST KIT PLUS WITH OR WITH OUT USA FDA EUA. WITHIN 23 MONTHS I WILL MARKET THE COVID19 TEST KIT ALL OVER ASIA AND OTHER PARTS OF WORLD WITH DR HERMAS CHAN AND WILL REPORT TO SHAREHOLDERS EVERY 45 DAYS THE SALES PROGRES WHICH WILL TRANSLATE INTO PROFITS FOR MIR WHICH IN TURN INTO PRICE OF MIR AT TSX.

ACTION MUST BE TAKEN NOW AS OTHER COMPANIES LIKE ABBOTT HAVE ALREADY ESTABLISTHED THEIR FOOTING EVEN IN SOUTH EAST ASIA.  
<< Previous
Bullboard Posts
Next >>